Clinical Study
Prognostic Value of Mandard and Dworak Tumor Regression Grading in Rectal Cancer: Study of a Single Tertiary Center
Table 4
Clinical long-term outcome, survival percent.
| ā | (%) | Mandard good response (%) | Mandard bad response (%) | value | Dworak good response (%) | Dworak bad response (%) | value |
| Five-year overall survival (OS) | 72.3 | 79.5 | 60.7 | 0.013 | 77.4 | 69.1 | 0.10 | (se = 4.2) | (se = 5.4) | (se = 6.3) | 0.010 | (se = 6.4) | (se = 5.5) | 0.047 |
| Five-year disease free survival (DFS) | 72.1 | 81.7 | 61.7 | 0.007 | 78.4 | 68.1 | 0.10 | (se = 4.1) | (se = 5.1) | (se = 6.3) | 0.004 | (se = 6.2) | (se = 5.4) | 0.047 |
|
|
Log rank test; Breslow test.
|